These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34322823)

  • 21. Women's health literacy and attendance in breast cancer screening: A Danish population-based study combining survey and register data.
    Egsgaard SD; Røssell EL; Sørensen JB; Støvring H
    Scand J Public Health; 2024 Jul; 52(5):573-581. PubMed ID: 37151045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma.
    Zackrisson S; Andersson I; Manjer J; Janzon L
    Int J Cancer; 2004 Feb; 108(5):754-60. PubMed ID: 14696103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of compression force and pressure at prevalent screening on subsequent re-attendance in a national screening program.
    Moshina N; Sebuødegård S; Holen ÅS; Waade GG; Tsuruda K; Hofvind S
    Prev Med; 2018 Mar; 108():129-136. PubMed ID: 29337068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in the use of mammography for early breast cancer detection in Switzerland: Swiss Health Surveys 2007 and 2012.
    Fenner L; Kässner A; Berlin C; Egger M; Zwahlen M
    Swiss Med Wkly; 2018; 148():w14603. PubMed ID: 29756635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mammographic surveillance of asymptomatic breast cancer relatives in general practice: rate of re-attendance and GP- and patient-related barriers.
    Duijm LE; Guit GL; Zaat JO
    Fam Pract; 1997 Dec; 14(6):450-4. PubMed ID: 9476075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychosocial predictors of first attendance for organised mammography screening.
    Aro AR; de Koning HJ; Absetz P; Schreck M
    J Med Screen; 1999; 6(2):82-8. PubMed ID: 10444726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Socio-economic and demographic determinants affecting participation in the Swedish cervical screening program: A population-based case-control study.
    Broberg G; Wang J; Östberg AL; Adolfsson A; Nemes S; Sparén P; Strander B
    PLoS One; 2018; 13(1):e0190171. PubMed ID: 29320536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance.
    Brett J; Austoker J
    J Public Health Med; 2001 Dec; 23(4):292-300. PubMed ID: 11873891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Age, Race, and Socioeconomic Status on Women's Perceptions and Preferences Regarding Communication of Estimated Breast Cancer Risk.
    Amornsiripanitch N; Ameri SM; Goldberg RJ
    Acad Radiol; 2021 May; 28(5):655-663. PubMed ID: 32376184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Service screening with mammography of women aged 50-69 years in Sweden: effects on mortality from breast cancer.
    Jonsson H; Nyström L; Törnberg S; Lenner P
    J Med Screen; 2001; 8(3):152-60. PubMed ID: 11678556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial Effect of Consecutive Screening Mammography Examinations on Mortality from Breast Cancer: A Prospective Study.
    Duffy SW; Tabár L; Yen AM; Dean PB; Smith RA; Jonsson H; Törnberg S; Chiu SY; Chen SL; Jen GH; Ku MM; Hsu CY; Ahlgren J; Maroni R; Holmberg L; Chen TH
    Radiology; 2021 Jun; 299(3):541-547. PubMed ID: 33650900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does Women's Screening History Have Any Impact on Mammography Screening Attendance After Tailored Education?: A Systematic Review and Meta-analysis.
    Brevik TB; Tropé A; Laake P; Bjørkly S
    Med Care; 2021 Oct; 59(10):893-900. PubMed ID: 34108408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women.
    Duffy SW; Tabár L; Yen AM; Dean PB; Smith RA; Jonsson H; Törnberg S; Chen SL; Chiu SY; Fann JC; Ku MM; Wu WY; Hsu CY; Chen YC; Svane G; Azavedo E; Grundström H; Sundén P; Leifland K; Frodis E; Ramos J; Epstein B; Åkerlund A; Sundbom A; Bordás P; Wallin H; Starck L; Björkgren A; Carlson S; Fredriksson I; Ahlgren J; Öhman D; Holmberg L; Chen TH
    Cancer; 2020 Jul; 126(13):2971-2979. PubMed ID: 32390151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examining screening mammography participation among women aged 40 to 74.
    Volesky KD; Villeneuve PJ
    Can Fam Physician; 2017 Jun; 63(6):e300-e309. PubMed ID: 28615408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telephone counseling and attendance in a national mammography-screening program a randomized controlled trial.
    Hegenscheid K; Hoffmann W; Fochler S; Domin M; Weiss S; Hartmann B; Bick U; Hosten N
    Am J Prev Med; 2011 Oct; 41(4):421-7. PubMed ID: 21961470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overdiagnosis in the population-based organized breast cancer screening program estimated by a non-homogeneous multi-state model: a cohort study using individual data with long-term follow-up.
    Wu WY; Törnberg S; Elfström KM; Liu X; Nyström L; Jonsson H
    Breast Cancer Res; 2018 Dec; 20(1):153. PubMed ID: 30558679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Attendance in the Norwegian Breast Cancer Screening Programme].
    Sebuødegård S; Sagstad S; Hofvind S
    Tidsskr Nor Laegeforen; 2016 Sep; 136(17):1448-51. PubMed ID: 27686204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
    Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
    JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with attendance at screening for breast cancer: a systematic review and meta-analysis.
    Mottram R; Knerr WL; Gallacher D; Fraser H; Al-Khudairy L; Ayorinde A; Williamson S; Nduka C; Uthman OA; Johnson S; Tsertsvadze A; Stinton C; Taylor-Phillips S; Clarke A
    BMJ Open; 2021 Nov; 11(11):e046660. PubMed ID: 34848507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.